Biomerica, Inc. (BMRA:NASDAQ) closed at $1.68 on October 23, 2026, unchanged on the day. The stock trades 45.6% below its 52-week high of $3.09 and 15.9% above its 52-week low of $1.45. Over the past year, it lost 43.2%. Biomerica, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, BMRA closed higher on 97 days (38%). Its best day was August 27, 2026 (+24.26%) and its worst was October 7, 2026 (-10.75%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions worldwide. Its diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. The company primarily focuses on products for gastrointestinal, food intolerances, diabetes, and esoteric tests. Biomerica, Inc. offers its products hospital and clinical laboratories, medical research institutions, medical schools, pharmaceutical companies, chain drugstores, wholesalers, and physicians' offices, as well as to distributors. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.
Find more stocks like BMRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.